Trump's Endorsement A Double-Edged Sword For Regeneron
October 09, 2020 at 06:15 AM EDT
President Trump's touting of Regeneron's COVID-19 treatment boosted the stock, but also added an element of political risk to it. We elaborate and show how cautious bulls can stay long while strictly limiting their risk.
